A simple, specific, and precise high-performance thin-layer chromatographic method has been developed and validated for estimation of Safinamide Mesylate as bulk and in tablet dosage form. The chromatographic development was carried out on aluminum plates precoated with silica gel 60 F254 using a mixture of Toluene: Methanol: Triethylamine (4 : 1 : 0.5 v/v) as mobile phase. Detection was carried out densitometrically at 226 nm. The 𝑅𝐹 value of drug was found to be 0.54±0.02. The method was validated with respect to linearity, accuracy, precision, and robustness. The calibration curve was found to be linear over a range of 400–2400 ng μL−1. The % assay (Mean ± S.D.) was found to be 100.27±0.72. Accuracy of the method was accessed by percentage recovery and found to be 99.77±0.71%. Thus the proposed HPTLC method was found to provide fast and cost-effective quantitative control for routine analysis of Safinamide mesylate as bulk and in tablet dosage form.
[1]
N. Xue,et al.
A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesilate, a new anti-Parkinson drug.
,
2011,
Journal of pharmaceutical and biomedical analysis.
[2]
M. Onofrj,et al.
An expert opinion on safinamide in Parkinson's disease
,
2008
.
[3]
M. Fibbioli,et al.
Bioassay of Safinamide in Biological Fluids of Humans and Various Animal Species
,
2006,
Arzneimittelforschung.
[4]
Carlo Cattaneo,et al.
Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity.
,
2004,
Pharmacological research.